Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis - Jawhar, Mohamad; Schwaab, Juliana; Metzgeroth, Georgia; Kluger, Sebastian; Naumann, Nicole; Hofmann, Wolf-Karsten; Fabarius, Alice; Reiter, Andreas (Leukemia, 2016)
Gesehen am 11.01.2019